Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,920 | -16,599 | -9,933 | -9,233 | 1,370 |
| Depreciation Amortization | 9,362 | 3,876 | 3,210 | 1,328 | 4,730 |
| Income taxes - deferred | -3,975 | -2,905 | -1,435 | -848 | -2,405 |
| Accounts receivable | 16,325 | 15,675 | 17,586 | 37,469 | -5,741 |
| Other Working Capital | 9,532 | -15,135 | -9,888 | 7,455 | -205 |
| Other Operating Activity | -14,553 | -10,845 | -9,416 | -30,308 | 11,655 |
| Operating Cash Flow | $-22,229 | $-25,933 | $-9,876 | $5,863 | $9,404 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,167 | -5,460 | -3,798 | -1,003 | -4,991 |
| Net Acquisitions | -9,443 | N/A | N/A | N/A | -525 |
| Investing Cash Flow | $-17,610 | $-5,460 | $-3,798 | $-1,003 | $-5,516 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 594 | 15,225 | 327 | -1,542 | -14,013 |
| Debt Issued | 12,000 | N/A | 711 | 728 | 2,300 |
| Debt Repayment | -4,775 | -4,247 | -4,152 | -3,627 | -8,279 |
| Common Stock Issued | 2,800 | 2,755 | 320 | 175 | 609 |
| Other Financing Activity | 9,534 | 0 | 0 | 0 | -1,567 |
| Financing Cash Flow | $20,153 | $13,733 | $-2,794 | $-4,266 | $-20,950 |
| Exchange Rate Effect | -451 | -2,310 | 629 | -1,587 | 1,625 |
| Beginning Cash Position | 27,940 | 27,940 | 27,940 | 27,940 | 43,377 |
| End Cash Position | 7,803 | 7,970 | 12,101 | 26,947 | 27,940 |
| Net Cash Flow | $-20,137 | $-19,970 | $-15,839 | $-993 | $-15,437 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,229 | -25,933 | -9,876 | 5,863 | 9,404 |
| Capital Expenditure | -8,167 | -5,460 | -3,798 | -1,003 | -5,036 |
| Free Cash Flow | -30,396 | -31,393 | -13,674 | 4,860 | 4,368 |